Insignia Financial has opened its books to Bain Capital after it matched CC Capital Partners' revised takeover offer. It comes as the wealth giant reports several achievements, including growth in its ...

INSIGNIA Financial’s shares hit a three-year high on Thursday (Jan 23), driven by a revised takeover offer of A$3.07 billion (S$2.6 billion) from US-based Bain Capital, matching the bid of rival CC ...

Insignia Financial has announced total quarterly net inflows of $2.3 billion as well as a third bid from Bain Capital. In its quarterly results for the three months to 31 December, it said total net ...

Insignia's shares peak to a 3-year high Due diligence to Bain, CC Capital granted Bain matches CC Capitals' A$4.43 apiece offer Jan 23 (Reuters) - Insignia Financial's (IFL.AX), opens new tab ...

Bain Capital, a global private investment firm, has proposed to acquire a significant minority shareholding in Dhoot Transmission Private Limited (DTPL) and its associate company, Dhoot Holdings ...

Bain Capital is in talks to acquire Mitsubishi Chemical Group's pharmaceutical business in a potential multibillion-dollar deal, a person familiar with the matter said, a transaction that could ...

Bain Capital is in talks to acquire Mitsubishi Chemical Group’s41880.31%increase; green up pointing triangle pharmaceutical business in a potential multibillion-dollar deal, a person familiar ...

TOKYO -- Japan's Mitsubishi Chemical Group has granted a first-refusal right to U.S. investment fund Bain Capital for the purchase of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma ...

Bain Capital has promoted Ivano Sessa to be co-head of European private equity as the investment firm is shaking up its leadership ranks in the region. The 47-year-old Italian will help lead the ...

Bain Capital has promoted Ivano Sessa to be co-head of European private equity as the investment firm is shaking up its leadership ranks in the region. The 47-year-old Italian will help lead the ...

Mitsubishi Chemical Group is stepping up its efforts to streamline operations by entering negotiations with U.S. investment fund Bain Capital to sell its pharmaceutical arm, Mitsubishi Tanabe Pharma.